Risk factors
ELI LILLY (LLY) risk factors
Item 1A of every ELI LILLY & Co. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors17 risks15 new1 dropped2 reworded
Mounjaro and Zepbound drove 56% of 2025 revenue, making cardiometabolic demand, competition, pricing, supply, and safety especially consequential.
Filed Feb 12, 2026